The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy.

[1]  B. Fraass,et al.  Peripheral dose from megavolt beams. , 1983, Medical physics.

[2]  N. Day,et al.  Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. , 1985, Journal of the National Cancer Institute.

[3]  Louis K. Wagner,et al.  Limitation of Exposure to Ionizing Radiation , 1994 .

[4]  A. B. Brill,et al.  NCRP Report No. 116, Limitation of Exposure to Ionizing Radiation National Council on Radiation Protection, Bethesda, MD, 88 pages, $22.50 , 1994 .

[5]  E. Hall,et al.  Photoneutrons from medical linear accelerators--radiobiological measurements and risk estimates. , 1995, International journal of radiation oncology, biology, physics.

[6]  D Followill,et al.  Estimates of whole-body dose equivalent produced by beam intensity modulated conformal therapy. , 1997, International journal of radiation oncology, biology, physics.

[7]  S Mutic,et al.  Whole-body dose from tomotherapy delivery. , 1998, International journal of radiation oncology, biology, physics.

[8]  D Verellen,et al.  Risk assessment of radiation-induced malignancies based on whole-body equivalent dose estimates for IMRT treatment in the head and neck region. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Whole-body dose from Peacock-based IMRT treatment , 2000 .

[10]  D. Brenner,et al.  Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery , 2000, Cancer.

[11]  E. Ron Ionizing radiation and cancer risk: evidence from epidemiology , 2002, Pediatric Radiology.

[12]  J. Buatti,et al.  In vivo determination of extra-target doses received from serial tomotherapy. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  E. Hall,et al.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.

[14]  A. D'Amico,et al.  Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Omar Chibani,et al.  Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs. , 2003, Medical physics.

[16]  David S Followill,et al.  Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.